Records containing: Huntington's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-10-10Working Memory Training in Individuals With Huntington's Disease: A Pilot Project
-
CLINICAL_TRIALS study record update · 2016-06-01[PETDE10] Imaging of Phosphodiesterase 10 A (PDE10A) Enzyme Levels in the Living Human Brain of Huntington´s Disease Gene Expansion Carriers and Healthy Controls With Positron Emission Tomography
-
CLINICAL_TRIALS study record update · 2016-03-30Coenzyme Q10 in Huntington's Disease (HD)
-
CLINICAL_TRIALS study record update · 2016-03-11Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
-
CLINICAL_TRIALS study record update · 2016-03-08Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 ( 5 mg, 10 mg, 20 mg and 40 mg ) in Healthy Young Male Volunteers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-11-25A Double-blind, Placebo-controlled Study in Huntington's Disease Patients to Determine the Safety and Tolerability of SEN0014196
-
CLINICAL_TRIALS study record update · 2015-09-16Functional Imaging of Social Cognition in Premanifest Huntington's Disease
-
CLINICAL_TRIALS study record update · 2015-06-08A Multi-Center, Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study of Dimebon in Subjects With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2015-03-25Minocycline Dosing and Safety in Huntington's Disease
-
CLINICAL_TRIALS study record update · 2014-09-09A Randomized, Double-blind, Placebo-controlled Prospective Crossover Trial Investigating the Efficacy and Safety of the Treatment With Bupropion in Patients With Apathy in Huntington's Disease
-
CLINICAL_TRIALS study record update · 2014-04-02ClinicalTrials.gov study NCT02101957
-
CLINICAL_TRIALS study record update · 2014-02-10Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study
-
CLINICAL_TRIALS study record update · 2014-02-10Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability
-
CLINICAL_TRIALS study record update · 2013-04-02A Randomized, Double-Blind, Placebo- And Active-Controlled Single-Dose, Crossover Study To Evaluate The Abuse Potential Of Single Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
-
CLINICAL_TRIALS study record update · 2013-03-20A Phase 1b, Open-label, Parallel-group Study in Subjects With Huntington Disease to Assess the Safety, Tolerability, and Fed/Fasted Pharmacokinetics of Repeated Oral Doses of SEN0014196
-
CLINICAL_TRIALS study record update · 2013-02-01A Double Blind, Randomized, Cross Over, Placebo Controlled Phase 2 Clinical Trial to Asses Neuroprotection by Cannabinoids in Huntington's Disease
-
CLINICAL_TRIALS study record update · 2012-11-06Treating Sleep Wake Cycle Disturbances in Basal Ganglia Neurodegenerative Disorder Subjects With Ramelteon- A Double Blind, Placebo Controlled Trial
-
CLINICAL_TRIALS study record update · 2012-09-11Single Centre (Pilot) Study for Deep Brain Stimulation (DBS) of the Globus Pallidus in Huntington's Disease (HD)
-
CLINICAL_TRIALS study record update · 2012-08-15Phenylbutyrate Development for Huntington's Disease (PHEND-HD): A Multi-Center, Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Tolerability of Phenylbutyrate in Subjects With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2012-08-03Cognitive Assessment Battery (CAB)Beta Study
-
CLINICAL_TRIALS study record update · 2012-02-07A Phase I, Randomised, Double-Blind, Placebo-Controlled, Two-Part Study Consisting of Single and Multiple Oral Dose Escalation to Determine, Safety, Tolerability and Pharmacokinetics of SEN0014196
-
CLINICAL_TRIALS study record update · 2011-09-23A Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multiple Oral Dose Titration Proof of Concept Study in Patients With Huntington's Disease to Assess the Efficacy, Safety and Tolerability of AFQ056 in Reducing Chorea
-
CLINICAL_TRIALS study record update · 2011-08-22The Effects of Music Therapy on Depression, Chorea and Other Symptoms of Huntington's Disease
-
CLINICAL_TRIALS study record update · 2011-04-26A Phase 1, Randomized, Subject- And Investigator-Blind, Sponsor-Open, Placebo-Controlled, Parallel-Cohort, Single-Dose Escalation, And Multiple-Dose Titration Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
-
CLINICAL_TRIALS study record update · 2010-08-16Examination of Quantitative Electroencephalographic Biomarkers in Huntington's Disease: A Pilot Project